GGHC
NXTM

Gilder Gagnon Howe & Co’s NxStage Medical Inc. NXTM Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,237
Closed -$369K – 298
2018
Q3 		$369K Hold
13,237
– – ﹤0.01% 247
2018
Q2 		$369K Hold
13,237
– – ﹤0.01% 243
2018
Q1 		$329K Sell
13,237
-115,313
-90% -$2.8M ﹤0.01% 254
2017
Q4 		$3.12M Sell
128,550
-1,447,749
-92% -$38.1M 0.04% 183
2017
Q3 		$43.5M Sell
1,576,299
-623,920
-28% -$16.6M 0.61% 51
2017
Q2 		$55.2M Sell
2,200,219
-2,755,411
-56% -$68.2M 0.82% 37
2017
Q1 		$133M Sell
4,955,630
-794,131
-14% -$21.9M 2.24% 5
2016
Q4 		$151M Sell
5,749,761
-140,948
-2% -$3.49M 2.97% 5
2016
Q3 		$147M Sell
5,890,709
-127,367
-2% -$2.97M 2.53% 5
2016
Q2 		$130M Sell
6,018,076
-29,938
-0.5% -$534K 2.59% 5
2016
Q1 		$90.7M Buy
6,048,014
+35,967
+0.6% +$603K 1.78% 12
2015
Q4 		$132M Buy
6,012,047
+827,097
+16% +$15.4M 2.12% 8
2015
Q3 		$81.8M Buy
5,184,950
+1,311,719
+34% +$21M 1.3% 20
2015
Q2 		$55.3M Sell
3,873,231
-64,902
-2% -$1.1M 0.73% 41
2015
Q1 		$68.1M Sell
3,938,133
-96,758
-2% -$1.71M 0.95% 37
2014
Q4 		$72.3M Buy
4,034,891
+284,964
+8% +$4.59M 1.08% 28
2014
Q3 		$49.2M Sell
3,749,927
-495,044
-12% -$6.67M 0.72% 39
2014
Q2 		$61M Sell
4,244,971
-44,858
-1% -$586K 0.81% 34
2014
Q1 		$54.7M Buy
+4,289,829
New +$56M 0.74% 43

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gilder Gagnon Howe & Co's NXTM Position: Q4 2018 in Review

Gilder Gagnon Howe & Co sold out of NxStage Medical Inc. (NXTM) in Q4 2018, closing a stake of 13,237 shares — an estimated $369K sold.

Gilder Gagnon Howe & Co first reported a position in NXTM in Q1 2014 and held it in 19 quarters. The position peaked at $151M in Q4 2016. 172 funds tracked by Wall St. Rank hold NXTM as of Q4 2018.

  • Gilder Gagnon Howe & Co reported no remaining NxStage Medical Inc. position as of Q4 2018 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 13,237 NxStage Medical Inc. shares in Q4 2018, an estimated $369K.
  • Gilder Gagnon Howe & Co first reported a position in NxStage Medical Inc. in Q1 2014 and held it in 19 quarters.
  • Gilder Gagnon Howe & Co's NxStage Medical Inc. position peaked at $151M in Q4 2016.
  • 172 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2018.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2018, filed 14 Feb 2019.